|
Volumn 1, Issue 5, 2005, Pages 423-429
|
Assessment in vitro of a novel therapeutic strategy for glioma, combining herpes simplex virus HSV1716-mediated oncolysis with gene transfer and targeted radiotherapy.
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
(3 IODOBENZYL)GUANIDINE;
NORADRENALIN TRANSPORTER;
ANIMAL;
ARTICLE;
CELL CULTURE;
CELL LINE;
CELL SURVIVAL;
COMPARATIVE STUDY;
DOSE RESPONSE;
DRUG EFFECT;
GENE TRANSFER;
GENETIC ENGINEERING;
GENETIC TRANSDUCTION;
GENETICS;
GLIOMA;
GROWTH, DEVELOPMENT AND AGING;
HAMSTER;
HERPES SIMPLEX VIRUS 1;
HUMAN;
IN VITRO STUDY;
KINETICS;
METHODOLOGY;
MOUSE;
MULTIMODALITY CANCER THERAPY;
ONCOLYTIC VIROTHERAPY;
PHYSIOLOGY;
RADIOTHERAPY;
STRUCTURE ACTIVITY RELATION;
TIME;
VIROLOGY;
3-IODOBENZYLGUANIDINE;
ANIMALS;
CELL LINE;
CELL SURVIVAL;
COMBINED MODALITY THERAPY;
COMPARATIVE STUDY;
CRICETINAE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
GENE TRANSFER TECHNIQUES;
GENETIC ENGINEERING;
GLIOMA;
HERPESVIRUS 1, HUMAN;
HUMANS;
IN VITRO;
KINETICS;
MICE;
NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS;
ONCOLYTIC VIROTHERAPY;
RADIOTHERAPY;
RESEARCH SUPPORT, NON-U.S. GOV'T;
STRUCTURE-ACTIVITY RELATIONSHIP;
TIME FACTORS;
TRANSDUCTION, GENETIC;
TUMOR CELLS, CULTURED;
|
EID: 33846046173
PISSN: 15734064
EISSN: None
Source Type: Journal
DOI: 10.2174/1573406054864124 Document Type: Article |
Times cited : (14)
|
References (0)
|